Previous close | 41.24 |
Open | 41.20 |
Bid | 41.36 x 900 |
Ask | 41.38 x 1100 |
Day's range | 40.63 - 41.24 |
52-week range | 33.33 - 43.84 |
Volume | |
Avg. volume | 3,484,577 |
Market cap | 83.478B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 13.80 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.47 (3.59%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it’s one of the biggest trends on the stock market right now, then you can take a look at the […]
Recently, Zacks.com users have been paying close attention to Glaxo (GSK). This makes it worthwhile to examine what the stock has in store.